Emily Symington

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Combination Therapy

Emergency Department

Skeletal Muscle

Glycemic Control

Top Venues

Haemophilia : the official journal of the World Federation of Hemophilia

This page only lists publications with an associated author ORCID identifier.

Publications

Emily Symington, Savita Rangarajan, William A Lester, Bella Madan, Glenn F Pierce, Priyanka Raheja, Tara M Robinson, Dane Osmond, Chris B Russell, Christian Vettermann, Suresh K Agarwal, Mingjin Li, Wing Yen Wong, Michael A Laffan
Long-term safety and efficacy outcomes of valoctocogene roxaparvovec gene transfer up to 6 years post-treatment. Haemophilia : the official journal of the World Federation of Hemophilia 30 (2) (2024)
Emily Symington, Savita Rangarajan, William A Lester, Bella Madan, Glenn F Pierce, Priyanka Raheja, Carolyn Millar, Dane Osmond, Mingjin Li, Tara M Robinson
Valoctocogene roxaparvovec gene therapy provides durable haemostatic control for up to 7 years for haemophilia A. Haemophilia : the official journal of the World Federation of Hemophilia (2024)
Emily Symington, Savita Rangarajan, William A Lester, Bella Madan, Glenn F Pierce, Priyanka Raheja, Tara M Robinson, Dane Osmond, Chris B Russell, Christian Vettermann, Suresh K Agarwal, Mingjin Li, Wing Yen Wong, Michael A Laffan
Long-term safety and efficacy outcomes of valoctocogene roxaparvovec gene transfer up to 6 years post-treatment. Haemophilia : the official journal of the World Federation of Hemophilia (2024)
Emily Symington, Savita Rangarajan, William A Lester, Bella Madan, Glenn F Pierce, Priyanka Raheja, Tara M Robinson, Dane Osmond, Chris B Russell, Christian Vettermann, Suresh K Agarwal, Mingjin Li, Wing Yen Wong, Michael A Laffan
Long-term safety and efficacy outcomes of valoctocogene roxaparvovec gene transfer up to 6 years post-treatment. Haemophilia : the official journal of the World Federation of Hemophilia 30 (2) (2024)